Reports on clinical trials, oncology breakthroughs, and global pandemic preparedness.
A vaccine candidate against Shigella, a leading cause of deadly diarrhoeal disease, prevented illness in 89% of vaccinated adults in a small trial. Researchers now want to test it in young children, who bear the heaviest burden of the disease.
An estimated 18,000 Americans across 45 states have fallen ill in what is on track to be the largest Cyclospora outbreak in US history, linked to contaminated iceberg lettuce from Mexico. The parasite's unusual biology makes it exceptionally hard to detect, trace, and stop.
The US Food and Drug Administration has approved Lipfendra (enlicitide), a once-daily pill that cuts LDL cholesterol by up to 59%, ending a decades-long era in which this class of drug was available only by injection.